SDCBP2 promotes tumor progression and is a novel ferroptosis-related prognostic biomarker in lung adenocarcinoma
This study demonstrates that SDCBP2 promotes tumor progression and is a novel ferroptosis-related prognostic biomarker for LUAD.
Authors
- Guoqing Zhang (ORCID: https://orcid.org/0000-0003-0110-8614)
- Tianliang Zhao (ORCID: https://orcid.org/0000-0001-8285-8315)
- Wei Liu
- Zhengpan Wei (ORCID: https://orcid.org/0000-0002-1034-2085)
- Kaishang Zhang
- Xinliang Gao (ORCID: https://orcid.org/0000-0002-6951-4785)
- Zelong Wang (ORCID: https://orcid.org/0000-0001-8517-6862)
- Xue Pan
- Zhuoyu Gu
- Wenbo Fan (ORCID: https://orcid.org/0000-0002-4525-9812)
- Shuang Yuan (ORCID: https://orcid.org/0000-0002-1986-4090)
- Xiangnan Li (ORCID: https://orcid.org/0000-0002-0981-8138)
- Shaowu Sun (ORCID: https://orcid.org/0009-0003-8325-7396)
- Mingbo Tang (ORCID: https://orcid.org/0000-0002-2226-2787)
Institutions
- Jilin University (CN)
- Zhengzhou University (CN)
- Zhengzhou University of Science and Technology (CN)
- Henan University of Engineering (CN)
- First Hospital of Jilin University (CN)
- Henan Cancer Hospital (CN)
- Zhengzhou Business University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Henan Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.3389/fimmu.2025.1692308
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00